HRT Financial exits WORK Medical stake after net sale

HRT Financial LP, a ten percent owner of WORK Medical Technology Group, reported mixed trades in the company’s common stock.

Rhea-AI Filing Summary

HRT Financial LP, a ten percent owner of WORK Medical Technology Group, reported mixed trades in the company’s common stock. On May 28, 2026, it made an open‑market purchase of 1,535,850 shares at $0.09 per share.

On May 29, 2026, HRT Financial then executed an open‑market sale of 2,619,607 shares at $0.10 per share, leaving reported direct holdings at 0 shares. Across both days, this represents a net sale of 1,083,757 shares of WORK Medical common stock.

Positive

• None.

Negative

• A ten percent owner, HRT Financial LP, executed a net sale of 1,083,757 shares of WORK Medical Technology Group common stock across May 28–29, 2026, reducing reported direct holdings from previously held levels to 0 shares.

Insights

Equity ownership analyst

Large shareholder’s net sale fully exits reported WOK position.

HRT Financial LP, identified as a ten percent owner, combined a sizeable open‑market purchase on May 28, 2026 with a larger sale on May 29, 2026. The purchase covered 1,535,850 common shares at $0.09 each, followed by a sale of 2,619,607 shares at $0.10.

After these transactions, reported direct holdings in WORK Medical common stock fell to 0 shares, implying a full exit of the visible position in this filing. The net effect is a 1,083,757‑share reduction in ownership. The filing does not discuss reasons or broader company fundamentals, so interpretation focuses strictly on this ownership change.

Insider Trade Summary

Net Seller: 1,083,757 shares

Net Sell 2 txns

Insider HRT FINANCIAL LP

Role 10% Owner

Bought 1,535,850 shs ($138K)

Sold 2,619,607 shs ($262K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,619,607	$0.10	$262K
Purchase	Common Stock	1,535,850	$0.09	$138K

Holdings After Transaction: Common Stock — 0 shares (Direct)

Key Figures

Shares purchased: 1,535,850 shares Purchase price: $0.09 per share Shares sold: 2,619,607 shares +3 more

6 metrics

Shares purchased 1,535,850 shares Open-market purchase on May 28, 2026 at $0.09

Purchase price $0.09 per share Common stock bought May 28, 2026

Shares sold 2,619,607 shares Open-market sale on May 29, 2026 at $0.10

Sale price $0.10 per share Common stock sold May 29, 2026

Net shares sold 1,083,757 shares Net of May 28–29, 2026 trades

Holdings after sale 0 shares Total shares following May 29, 2026 transaction

Key Terms

open-market sale, open-market purchase, ten percent owner, non-derivative, +1 more

5 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

open-market purchase financial

"transaction_action": "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

ten percent owner financial

""is_ten_percent_owner": 1"

non-derivative financial

""transaction_type": "non-derivative""

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did HRT Financial LP report for WORK Medical Technology Group (WOK)?

HRT Financial LP reported one purchase and one sale of WORK Medical common stock. It bought 1,535,850 shares at $0.09 on May 28, 2026, then sold 2,619,607 shares at $0.10 on May 29, 2026, according to the Form 4.

Did HRT Financial LP increase or decrease its stake in WORK Medical Technology Group (WOK)?

HRT Financial LP decreased its reported stake in WORK Medical. The Form 4 shows a net sale of 1,083,757 shares across two days, with total reported direct holdings in the company’s common stock falling to zero after the May 29, 2026 transaction.

How many WORK Medical (WOK) shares did HRT Financial LP buy and at what price?

HRT Financial LP bought 1,535,850 WORK Medical common shares. The open‑market purchase occurred on May 28, 2026, at a price of $0.09 per share, as disclosed in the non‑derivative transaction section of the Form 4 filing.

How many WORK Medical (WOK) shares did HRT Financial LP sell and at what price?

HRT Financial LP sold 2,619,607 WORK Medical common shares. This open‑market sale took place on May 29, 2026, at a price of $0.10 per share, resulting in reported direct ownership of zero shares after the transaction.

What is the net effect of HRT Financial LP’s recent trades in WORK Medical (WOK) stock?

The net effect is a reduction of 1,083,757 WORK Medical shares. HRT Financial LP bought 1,535,850 shares at $0.09, then sold 2,619,607 shares at $0.10, leading to zero reported direct holdings following the May 29, 2026 sale.

What type of transactions did HRT Financial LP use for its WORK Medical (WOK) trades?

Both trades were open‑market transactions in WORK Medical common stock. The Form 4 describes the May 28, 2026 activity as an open‑market purchase and the May 29, 2026 activity as an open‑market sale, with no derivative exercises reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 05:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HRT FINANCIAL LP

(Last) (First) (Middle)

3 WORLD TRADE CENTER, 175 GREENWICH STRE

76TH FLOOR

(Street)

NEW YORK NEW YORK 10007

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
WORK Medical Technology Group LTD [ WOK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/28/2026		P		1,535,850	A	$0.09	225,234	D
Common Stock	05/29/2026		S		2,619,607	D	$0.1	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Adam Nunes	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)